Low antibodies against Plasmodium falciparum and imbalanced pro-inflammatory cytokines are associated with severe malaria in Mozambican children: A case-control study

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Rovira Vallbona, Eduard ^a   Moncunill, Gemma ^a   Bassat, Quique ^a,b   Aguilar, Ruth ^a,b   MacHevo, Sonia ^b   Puyol, Laura ^a   Quintá, Llorenç ^a   Menéndez, Clara ^a,b   Chitnis, Chetan E ^c   Alonso, Pedro L ^a,b   Dobão, Carlota ^a,b   Mayor, Alfredo ^a,b  

^a CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^b Ministério de Saúde   (Mozambique)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY ICGEB   (India)

Author keywords

Antibodies; Children; Cytokines; Plasmodium falciparum; Severe malaria

Indexed keywords

APICAL MEMBRANE ANTIGEN 1; ARTESUNATE; CHEMOKINE; CYTOKINE; DUFFY BINDING LIKE ALPHA; DUFFY BINDING PROTEIN; ERYTHROCYTE BINDING ANTIGEN 175; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; LYMPHOTOXIN; MEROZOITE SURFACE PROTEIN 1; PARASITE ANTIGEN; PROTOZOON ANTIBODY; PYRIMETHAMINE PLUS SULFADOXINE; QUININE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ACIDOSIS; ANTIBODY RESPONSE; ARTICLE; BRAIN MALARIA; CASE CONTROL STUDY; CELL LYSATE; CHILD; CONTROLLED STUDY; CYTOKINE RESPONSE; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE; FEMALE; FLOW CYTOMETRY; FLUORESCENT BEAD IMMUNOASSAY; HUMAN; HYPOGLYCEMIA; IMMUNOASSAY; IMMUNOGLOBULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MOZAMBIQUE; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PROTEIN BLOOD LEVEL; RESPIRATORY DISTRESS; SEIZURE;

EID: 84861544808     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-181     Document Type: Article

References (64)

1. WHO, World Malaria Report Geneva: World Health Organization 2011
2. The pathogenic basis of malaria. Miller LH, Baruch DI, Marsh K, Doumbo OK, Nature 2002 415 673 679 10.1038/415673a 11832955
3. Acquired immunity to malaria. Doolan DL, Dobão C, Baird JK, Clin Microbiol Rev 2009 22 13 36 10.1128/CMR.00025-08 19136431
4. Gamma-globulin and acquired immunity to human malaria. Cohen S, McGregor IA, Carrington S, Nature 1961 192 733 737 10.1038/192733a0 13880318
5. Human cerebral malaria: association with erythrocyte rosetting and lack of anti-rosetting antibodies. Carlson J, Helmby H, Hill AV, Brewster D, Greenwood BM, Wahlgren M, Lancet 1990 336 1457 1460 10.1016/0140-6736(90)93174-N 1979090
6. The C-terminal segment of the cysteine-rich interdomain of Plasmodium falciparum erythrocyte membrane protein 1 determines CD36 binding and elicits antibodies that inhibit adhesion of parasite-infected erythrocytes. Mo M, Lee HC, Kotaka M, Niang M, Gao X, Iyer JK, Lescar J, Preiser P, Infect Immun 2008 76 1837 1847 10.1128/IAI.00480-07 18299339
7. Differential antibody responses to Plasmodium falciparum merozoite proteins in Malawian children with severe malaria. Dobão C, Rogerson SJ, Mackinnon MJ, Cavanagh DR, Taylor TE, Molyneux ME, McBride JS, J Infect Dis 2008 197 766 774 10.1086/527490 18260767
8. High titers of IgG antibodies against Plasmodium falciparum serine repeat antigen 5 (SERA5) are associated with protection against severe malaria in Ugandan children. Okech B, Mujuzi G, Ogwal A, Shirai H, Horii T, Egwang TG, AmJTrop Med Hyg 2006 74 191 197
9. Severe malaria in Gambian children is not due to lack of previous exposure to malaria. Erunkulu OA, Hill AV, Kwiatkowski DP, Todd JE, Iqbal J, Berzins K, Riley EM, Greenwood BM, Clin Exp Immunol 1992 89 296 300 1638773
10. Low antibody responses to variant surface antigens of Plasmodium falciparum are associated with severe malaria and increased susceptibility to malaria attacks in Gabonese children. Tebo AE, Kremsner PG, Piper KP, Luty AJ, AmJTrop Med Hyg 2002 67 597 603
11. Antibody responses to a panel of Plasmodium falciparum malaria blood-stage antigens in relation to clinical disease outcome in Sudan. Iriemenam NC, Khirelsied AH, Nasr A, ElGhazali G, Giha HA, Elhassan AETM, Agab-Aldour AA, Montgomery SM, Anders RF, Theisen M, Troye-Blomberg M, Elbashir MI, Berzins K, Vaccine 2009 27 62 71 10.1016/j.vaccine.2008.10.025 18977268
12. Antibody responses to Plasmodium falciparum: evolution according to the severity of a prior clinical episode and association with subsequent reinfection. Luty AJ, Ulbert S, Lell B, Lehman L, Schmidt-Ott R, Luckner D, Greve B, Matousek P, Schmid D, Herbich K, Dubois B, Deloron P, Kremsner PG, AmJTrop Med Hyg 2000 62 566 572
13. Impairment of Plasmodium falciparum-specific antibody response in severe malaria. Brasseur P, Ballet JJ, Druilhe P, J Clin Microbiol 1990 28 265 268 2179259
14. Immunological evaluation of cell-mediated and humoral immunity in Thai patients with cerebral and non cerebral Plasmodium falciparum malaria: II. Evolution of serum levels of immunoglobulins, antimalarial antibodies, complement fractions and alpha interferon. Fribourg-Blanc A, Druilhe P, Brasseur P, Rhodes-Feuillette A, Ballet JJ, Tharavanij S, Southeast Asian J Trop Med Public Health 1985 16 307 313 3906923
15. Interleukin 12 induction of interferon gamma-dependent protection against malaria. Sedegah M, Finkelman F, Hoffman SL, Proc Natl Acad Sci U S A 1994 91 10700 10702 10.1073/pnas.91.22.10700 7938013
16. Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production. Kremsner PG, Winkler S, Brandts C, Wildling E, Jenne L, Graninger W, Prada J, Bienzle U, Juillard P, Grau GE, AmJTrop Med Hyg 1995 53 532 538
17. Sterile protection of monkeys against malaria after administration of interleukin-12. Hoffman SL, Crutcher JM, Puri SK, Ansari AA, Villinger F, Franke ED, Singh PP, Finkelman F, Gately MK, Dutta GP, Sedegah M, Nat Med 1997 3 80 83 10.1038/nm0197-80 8986746
18. Clinical features and pathogenesis of severe malaria. Mackintosh CL, Beeson JG, Marsh K, Trends Parasitol 2004 20 597 603 10.1016/j.pt.2004.09.006 15522670
19. Murine AIDS protects mice against experimental cerebral malaria: down-regulation by interleukin 10 of a T-helper type 1 CD4+ cell-mediated pathology. Eckwalanga M, Marussig M, Tavares MD, Bouanga JC, Hulier E, Pavlovitch JH, Minoprio P, Portnoi D, Renia L, Mazier D, Proc Natl Acad Sci U S A 1994 91 8097 8101 10.1073/pnas.91.17.8097 8058763
20. Interleukin-10 inhibits tumor necrosis factor production but not antigen-specific lymphoproliferation in acute Plasmodium falciparum malaria. Ho M, Sexton MM, Tongtawe P, Looareesuwan S, Suntharasamai P, Webster HK, J Infect Dis 1995 172 838 844 10.1093/infdis/172.3.838 7658079
21. Transforming growth factor beta production is inversely correlated with severity of murine malaria infection. Omer FM, Riley EM, J Exp Med 1998 188 39 48 10.1084/jem.188.1.39 9653082
22. Reduced interleukin-12 and transforming growth factor-beta1 in severe childhood malaria: relationship of cytokine balance with disease severity. Perkins DJ, Weinberg JB, Kremsner PG, J Infect Dis 2000 182 988 992 10.1086/315762 10950804
23. Malaria in rural Mozambique. Part II: children admitted to hospital. Bassat Q, Guinovart C, Sigauque B, Aide P, Sacarlal J, Nhampossa T, Bardaji A, Nhacolo A, Macete E, Mandomando I, Aponte JJ, Menéndez C, Alonso P, Malar J 2008 7 37 10.1186/1475-2875-7-37 18302771
24. Alonso P, Saúte F, Aponte JJ, Gámez-Olivé FX, Nhacolo A, Thomson R, Macete E, Abacassamo F, Ventura PJ, Bosch X, Menéndez C, Dgedge M, Manhiça DSS, Mozambique. Population, Health and Survival at INDEPTH Sites. Volume 1 Ottawa: INDEPTH Network 2001 189 195 9853356
25. Association of severe malaria outcomes with platelet-mediated clumping and adhesion to a novel host receptor. Mayor A, Hafiz A, Bassat Q, Rovira-Vallbona E, Sanz S, Machevo S, Aguilar R, Cisterá P, Sigaúque B, Menéndez C, Alonso PL, Chitnis CE, PLoS One 2011 6 19422 10.1371/journal.pone.0019422 21559373
26. Malaria in southern Mozambique: malariometric indicators and malaria case definition in Manhica district. Saute F, Aponte J, Almeda J, Ascaso C, Abellana R, Vaz N, Dgedge M, Alonso P, Trans R Soc Trop Med Hyg 2003 97 661 666 10.1016/S0035-9203(03)80098-6 16117958
27. Efficacy of the RTS, S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial. Alonso PL, Sacarlal J, Aponte JJ, Leach A, Macete E, Milman J, Mandomando I, Spiessens B, Guinovart C, Espasa M, Bassat Q, Aide P, Ofori-Anyinam O, Navia MM, Corachan S, Ceuppens M, Dubois MC, Demoitie MA, Dubovsky F, Menendez C, Tornieporth N, Ballou WR, Thompson R, Cohen J, Lancet 2004 364 1411 1420 10.1016/S0140-6736(04)17223-1 15488216
28. Detection of Plasmodium falciparum malaria parasites in vivo by real-time quantitative PCR. Hermsen CC, Telgt DSC, Linders EHP, van de Locht LATF, Eling WMC, Mensink EJBM, Sauerwein RW, Mol Biochem Parasitol 2001 118 247 251 10.1016/S0166-6851(01)00379-6 11738714
29. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Snounou G, Zhu X, Siripoon N, Jarra W, Thaithong S, Brown KN, Viriyakosol S, Trans R Soc Trop Med Hyg 1999 93 369 374 10.1016/S0035-9203(99)90120-7 10674079
30. Identification of cultivation condition to produce correctly folded form of a malaria vaccine based on Plasmodium falciparum merozoite surface protein-1 in Escherichia coli. Mazumdar S, Sachdeva S, Chauhan VS, Yazdani SS, Bioprocess Biosyst Eng 2010 33 719 730 10.1007/s00449-009-0394-x 19921275
31. Bacterially expressed and refolded receptor binding domain of Plasmodium falciparum EBA-175 elicits invasion inhibitory antibodies. Pandey KC, Singh S, Pattnaik P, Pillai CR, Pillai U, Lynn A, Jain SK, Chitnis CE, Mol Biochem Parasitol 2002 123 23 33 10.1016/S0166-6851(02)00122-6 12165386
32. High-level expression of the malaria blood-stage vaccine candidate Plasmodium falciparum apical membrane antigen 1 and induction of antibodies that inhibit erythrocyte invasion. Kocken CH, Withers-Martinez C, Dubbeld MA, van der Wel A, Hackett F, Valderrama A, Blackman MJ, Thomas AW, Infect Immun 2002 70 4471 4476 10.1128/IAI.70.8.4471-4476.2002 12117958
33. Functional and immunological characterization of a Duffy binding-like alpha domain from Plasmodium falciparum erythrocyte membrane protein 1 that mediates rosetting. Mayor A, Rovira-Vallbona E, Srivastava A, Sharma SK, Pati SS, Puyol L, Quinto L, Bassat Q, Machevo S, Mandomando I, Chauhan VS, Alonso PL, Chitnis CE, Infect Immun 2009 77 3857 3863 10.1128/IAI.00049-09 19546191
34. Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy. Mayor A, Rovira-Vallbona E, Machevo S, Bassat Q, Aguilar R, Quinto L, Jimenez A, Sigauque B, Dobano C, Kumar S, Singh B, Gupta P, Chauhan VS, Chitnis CE, Alonso PL, Menéndez C, Infect Immun 2011 79 1654 1659 10.1128/IAI.01000-10 21300778
35. P. falciparum rosetting mediated by a parasite-variant erythrocyte membrane protein and complement-receptor 1. Rowe JA, Moulds JM, Newbold CI, Miller LH, Nature 1997 388 292 295 10.1038/40888 9230440
36. Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. Ockenhouse CF, Ho M, Tandon NN, Van Seventer GA, Shaw S, White NJ, Jamieson GA, Chulay JD, Webster HK, J Infect Dis 1991 164 163 169 10.1093/infdis/164.1.163 1711552
37. A single member of the Plasmodium falciparum var multigene family determines cytoadhesion to the placental receptor chondroitin sulphate A. Viebig NK, Gamain B, Scheidig C, Lepolard C, Przyborski J, Lanzer M, Gysin J, Scherf A, EMBO Rep 2005 6 775 781 10.1038/sj.embor.7400466 16025132
38. Antibodies to variant surface antigens of Plasmodium falciparum-infected erythrocytes and adhesion inhibitory antibodies are associated with placental malaria and have overlapping and distinct targets. Beeson JG, Mann EJ, Elliott SR, Lema VM, Tadesse E, Molyneux ME, Brown GV, Rogerson SJ, J Infect Dis 2004 189 540 551 10.1086/381186 14745713
39. Resampling-based methods for the analysis of multiple endpoints in clinical trials. Reitmeir P, Wassmer G, Stat Med 1999 18 3453 3462 10.1002/(SICI)1097-0258(19991230)18:24<3453::AID-SIM283>3.0.CO;2-Z 10611618
40. Cytokine profiles and antibody responses to Plasmodium falciparum malaria infection in individuals living in Ibadan, southwest Nigeria. Iriemenam NC, Okafor CM, Balogun HA, Ayede I, Omosun Y, Persson JO, Hagstedt M, Anumudu CI, Nwuba RI, Troye-Blomberg M, Berzins K, Afr Health Sci 2009 9 66 74 19652739
41. Sequential, Ordered Acquisition of Antibodies to Plasmodium falciparum Erythrocyte Membrane Protein 1 Domains. Cham GK, Turner L, Lusingu J, Vestergaard L, Mmbando BP, Kurtis JD, Jensen ATR, Salanti A, Lavstsen T, Theander TG, J Immunol 2009 183 3356 3363 10.4049/jimmunol.0901331 19675168
42. Acquisition of naturally occurring antibody responses to recombinant protein domains of Plasmodium falciparum erythrocyte membrane protein 1. Mackintosh CL, Christodoulou Z, Mwangi TW, Kortok M, Pinches R, Williams TN, Marsh K, Newbold CI, Malar J 2008 7 155 10.1186/1475-2875-7-155 18706102
43. al-Yaman F, Wahlgren M: Natural protection against severe Plasmodium falciparum malaria due to impaired rosette formation. Carlson J, Nash GB, Gabutti V, Blood 1994 84 3909 3914 7949147
44. Transcription of var genes other than var2csa in Plasmodium falciparum parasites infecting Mozambican pregnant women. Rovira-Vallbona E, Dobão C, Bardají A, Cisterá P, Romagosa C, Serra-Casas E, Quinto L, Bassat Q, Sigaúque B, Alonso PL, Ordi J, Menéndez C, Mayor A, J Infect Dis 2011 204 27 35 10.1093/infdis/jir217 21628655
45. A Plasma Survey Using 38 PfEMP1 Domains Reveals Frequent Recognition of the Plasmodium falciparum Antigen VAR2CSA among Young Tanzanian Children. Oleinikov AV, Voronkova VV, Frye IT, Amos E, Morrison R, Fried M, Duffy PE, PLoS One 2012 7 31011 10.1371/journal.pone.0031011 22295123
46. Possible role of specific immunoglobulin M antibodies to Plasmodium falciparum antigens in immunoprotection of humans living in a hyperendemic area, Burkina Faso. Boudin C, Chumpitazi B, Dziegiel M, Peyron F, Picot S, Hogh B, Ambroise-Thomas P, J Clin Microbiol 1993 31 636 641 8458956
47. Cohort study of the association of antibody levels to AMA1, MSP119, MSP3 and GLURP with protection from clinical malaria in Ghanaian children. Dodoo D, Aikins A, Kusi KA, Lamptey H, Remarque E, Milligan P, Bosomprah S, Chilengi R, Osei YD, Akanmori BD, Theisen M, Malar J 2008 7 142 10.1186/1475-2875-7-142 18664257
48. Parasite-specific IgM plays a significant role in the protective immune response to asexual erythrocytic stage Plasmodium chabaudi AS infection. Couper KN, Phillips RS, Brombacher F, Alexander J, Parasite Immunol 2005 27 171 180 10.1111/j.1365-3024.2005.00760.x 15987340
49. Malaria exoantigens induce T-independent antibody that blocks their ability to induce TNF. Bate CA, Taverne J, Dave A, Playfair JH, Immunology 1990 70 315 320 2379940
50. Genetic polymorphisms linked to susceptibility to malaria. Driss A, Hibbert JM, Wilson NO, Iqbal SA, Adamkiewicz TV, Stiles JK, Malar J 2011 10 271 10.1186/1475-2875-10-271 21929748
51. Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya. Malhotra I, Dent A, Mungai P, Wamachi A, Ouma JH, Narum DL, Muchiri E, Tisch DJ, King CL, PLoS Med 2009 6 1000116 10.1371/journal.pmed.1000116 19636353
52. Therapeutic blockade of PD-L1 and LAG-3 rapidly clears established blood-stage Plasmodium infection. Butler NS, Moebius J, Pewe LL, Traore B, Doumbo OK, Tygrett LT, Waldschmidt TJ, Crompton PD, Harty JT, Nat Immunol 2011 13 188 195 10.1038/ni.2180 22157630
53. Atypical memory B cells are greatly expanded in individuals living in a malaria-endemic area. Weiss GE, Crompton PD, Li S, Walsh LA, Moir S, Traore B, Kayentao K, Ongoiba A, Doumbo OK, Pierce SK, J Immunol 2009 183 2176 2182 10.4049/jimmunol.0901297 19592645
54. Serum levels of the proinflammatory cytokines interleukin-1 beta (IL-1beta), IL-6, IL-8, IL-10, tumor necrosis factor alpha, and IL-12(p70) in Malian children with severe Plasmodium falciparum malaria and matched uncomplicated malaria or healthy controls. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein MB, Infect Immun 2004 72 5630 5637 10.1128/IAI.72.10.5630-5637.2004 15385460
55. Increased levels of inflammatory mediators in children with severe Plasmodium falciparum malaria with respiratory distress. Awandare GA, Goka B, Boeuf P, Tetteh JK, Kurtzhals JA, Behr C, Akanmori BD, J Infect Dis 2006 194 1438 1446 10.1086/508547 17054074
56. Tumor necrosis factor and disease severity in children with falciparum malaria. Grau GE, Taylor TE, Molyneux ME, Wirima JJ, Vassalli P, Hommel M, Lambert PH, N Engl J Med 1989 320 1586 1591 10.1056/NEJM198906153202404 2657427
57. Low interleukin-12 activity in severe Plasmodium falciparum malaria. Luty AJ, Perkins DJ, Lell B, Schmidt-Ott R, Lehman LG, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Weinberg JB, Kremsner PG, Infect Immun 2000 68 3909 3915 10.1128/IAI.68.7.3909-3915.2000 10858202
58. Ong'echa JM, Ounah D, Hittner JB, Vulule JM, Perkins DJ: Acquisition of hemozoin by monocytes down-regulates interleukin-12 p40 (IL-12p40) transcripts and circulating IL-12p70 through an IL-10-dependent mechanism: in vivo and in vitro findings in severe malarial anemia. Keller CC, Yamo O, Ouma C, Infect Immun 2006 74 5249 5260 10.1128/IAI.00843-06 16926419
59. Challenges in infant immunity: implications for responses to infection and vaccines. PrabhuDas M, Adkins B, Gans H, King C, Levy O, Ramilo O, Siegrist CA, Nat Immunol 2011 12 189 194 21321588
60. Age-dependent maturation of Toll-like receptor-mediated cytokine responses in Gambian infants. Burl S, Townend J, Njie-Jobe J, Cox M, Adetifa UJ, Touray E, Philbin VJ, Mancuso C, Kampmann B, Whittle H, Jaye A, Flanagan KL, Levy O, PLoS One 2011 6 18185 10.1371/journal.pone.0018185 21533209
61. Neonatal adaptive immunity comes of age. Adkins B, Leclerc C, Marshall-Clarke S, Nat Rev Immunol 2004 4 553 564 10.1038/nri1394 15229474
62. Schistosoma haematobium infection affects Plasmodium falciparum-specific IgG responses associated with protection against malaria. Courtin D, Djilali-Saiah A, Milet J, Soulard V, Gaye O, Migot-Nabias F, Sauerwein R, Garcia A, Luty AJ, Parasite Immunol 2011 33 124 131 10.1111/j.1365-3024.2010.01267.x 21226725
63. Consequences of HIV infection on malaria and therapeutic implications: a systematic review. Flateau C, Le Loup G, Pialoux G, Lancet Infect Dis 2011 11 541 556 10.1016/S1473-3099(11)70031-7 21700241
64. Pathophysiology of severe malaria in children. Maitland K, Marsh K, Acta Trop 2004 90 131 140 10.1016/j.actatropica.2003.11.010 15177139